Amgen gets injunction against Novartis biosimilar drug NephrologyNews.com A U.S. appeals court has blocked the sale of Novartis AG's Zarxio, a recently approved biosimilar form of Amgen Inc.'s cancer drug Neupogen, which is used to prevent infections in cancer patients undergoing chemotherapy. On May 5, the U.S. Court of ...
